ShockWave Medical SWAV 深 沪
已收盘 05-31 16:00:00 美东时间
334.75
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 334.75
- 总市值 123.02亿
- 52周最高 334.90
- 市盈率 静 86.84
- 换手率 0.00%
- 52周最低 157.00
- 委 比 0.00%
- 总股本 3675.04万
- 历史最高 334.90
- 量 比 0
- 振 幅 0.00%
- 历史最低 22.01
- 每 手 1
- 风险率 0.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Med-tech and healthcare stocks with upside during 2Q earnings - Baird
Baird analysts outlined stocks within medical technology where they see an upside during the second quarter’s earnings. Healthcare and med-tech has underperformed the broader market year-to-date, but ...
2024-07-18 23:34
J&J completes acquisition of cardiac device maker Shockwave
Johnson & Johnson (NYSE:JNJ) said it has completed its acquisition of Shockwave Medical (SWAV), which will now operate under its MedTech division. The deal is expected to be dilutive to adjusted earni...
2024-05-31 21:35
Why Sarepta Therapeutics Stock Is Rising Today
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stock is trading higher on Thursday after it was announced the company will be added to the S&P MidCap 400.
2024-05-31 02:20
Sarepta Therapeutics To Join S&P Midcap 400, Effective June 3
Sarepta Therapeutics will replace Shockwave Medical in the S&P MidCap 400 effective prior to the opening of trading on Monday, June 3. S&P 500 constituent Johnson & Johnson is acquiring
2024-05-30 05:20
8.5亿美元！强生收购一家双抗新药公司
转自：新康界 5月16日，强生宣布与Proteologix公司达成一项协议，将以 8.5 亿美元现金收购后者。除了 8.5 亿美元现金外，Proteologi...
2024-05-19 17:50
Maintaining Hold: Shockwave Medical’s Solid Performance Tempered by Market Valuation
Analyst Larry Biegelsen from Wells Fargo maintained a Hold rating on Shockwave ...
2024-05-09 17:19
Kuehn Law Encourages SWAV, ALE, PRFT, and LSAK Investors to Contact Law Firm
NEW YORK, May 8, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek a...
2024-05-09 03:12
ShockWave Medical Q1 EPS $1.44 Beats $0.98 Estimate, Sales $218.81M Beat $207.69M Estimate
ShockWave Medical (NASDAQ:SWAV) reported quarterly earnings of $1.44 per share which beat the analyst consensus estimate of $0.98 by 46.94 percent. This is a 39.81 percent increase over earnings of $1.03 per share from
2024-05-07 04:05
ShockWave Medical Q1 2024 Earnings Preview
ShockWave Medical (NASDAQ:SWAV) is scheduled to announce Q1 earnings results on Monday, May 6th, after market close. The consensus EPS Estimate is $0.93 (-9.7% Y/Y) and the consensus Revenue Estimate ...
2024-05-04 05:20
Disney To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
2024-04-08 20:00
